Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.35 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA5A | P35218 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3972409 | 0.70 | TSHR (0.52) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL4259159 | 0.69 | TSHR (0.50) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL1336610 | 0.69 | KCNN4 (0.56) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL5250544 | 0.67 | KCNN4 (0.48) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL8800379 | 0.67 | TSHR (0.48) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL28067360 | 0.65 | TSHR (0.46) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| Trifluoromethylbenzene SCHEMBL28205538 | 0.64 | TSHR (0.88) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL5609995 | 0.64 | TSHR (0.58) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL812047 | 0.64 | ALDH1A1 (0.44) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL28134027 | 0.64 | ALDH1A1 (0.42) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1439170-B1 | Fluorinating reactants and process for their preparation | SALTIGO GMBH (DE) | 2009-06-03 | — | — | EP | claimed |
| US-7045662-B2 | α, α-difluoroamines and difluoromethylene-α, α-diazo compounds | BAYER CHEMICALS AG (DE) | 2006-05-16 | — | — | US | claimed |
| US-20040198975-A1 | Alpha, alpha-difluoroamines and difluoromethylene-alpha, alpha-diazo compounds | LANXESS DEUTSCHLAND GMBH (DE) | 2004-10-07 | — | — | US | claimed |
| US-7045662-B2 | α, α-difluoroamines and difluoromethylene-α, α-diazo compounds | BAYER CHEMICALS AG (DE) | 2006-05-16 | — | — | US | disclosed |
| US-20040198975-A1 | Alpha, alpha-difluoroamines and difluoromethylene-alpha, alpha-diazo compounds | LANXESS DEUTSCHLAND GMBH (DE) | 2004-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040198975-A1 | Alpha, alpha-difluoroamines and difluoromethylene-alpha, alpha-diazo compounds | DDT, DDO, SAT1 | TSHR 2122/4885ALDH1A1 365/4885PTPN1 2965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.